News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Chides Celgene (CELG), Novartis AG (NVS) on Drug Promotion


1/26/2012 9:15:06 AM

Health regulators said drugmakers Celgene Corp and Novartis AG misrepresented their cancer drugs to doctors, overstating how well the medicines targeted tumors without having evidence to support it. The complaints concern Celgene's breast cancer drug Abraxane and Novartis's cancer drug Gleevec. The Food and Drug Administration posted separate letters to each company on its website on Wednesday, asking them to stop using advertising that violates FDA guidelines. The FDA inspects companies' marketing materials to make sure they do not illegally promote drugs for uses other than those approved by the agency, or make false claims that are not backed by clinical data.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES